A veterinarian's journey into real estate investment
Subscribe to The Vet Blast Podcast on Apple Podcasts, Spotify, or wherever you get your podcasts.
In 2020, Jason Balara, DVM, DACVS(SA), co-founder and chief executive officer of Lark Captial Group, transitioned to real estate syndication, allowing him to invest in large-scale projects. He discusses the importance of balancing his veterinary practice with his real estate ventures and emphasizes the significance of creating financial stability for his family's future.
On this week's episode of The Vet Blast Podcast, host Adam Christman, DVM, MBA, and Balara discuss his background in both veterinary medicine and real estate to show listeners the power of investing in real estate, plus what Lark Veterinary Impact Fund is and what Balara hopes to achieve through the fund.
Below is a partial transcript
Jason Balara, DVM, DACVS(SA): You want to do a little bit of research, find out what [multifamily real estate] means. There's lots of different websites out there we have one, everybody who does syndication has one. It's not necessarily hard to find the information but at the end of the day, you're going to have to take action. And as a passive investor, you're investing your hard-earned money with someone who is going to operate that real estate deal. And so what I would say is, you need to find that someone. You need to go out there and find someone who you like and trust and believe that they're going to have your best interests in mind. And I feel like I can represent that well in the veterinary world. But if someone is interested in investing and doesn't want to invest with me, guess what, I have a bunch of friends in the real estate world, I can point you in that direction, but it's establishing the relationships, but more than that, it's just about taking action and believing that this is important for your future.
Podcast CE: Using Novel Targeted Treatment for Canine Allergic and Atopic Dermatitis
December 20th 2024Andrew Rosenberg, DVM, and Adam Christman, DVM, MBA, talk about shortcomings of treatments approved for canine allergic and atopic dermatitis and react to the availability of a novel JAK inhibitor.
Listen
Size of Phoenix pharmacy compounding facility has nearly doubled
December 11th 2024Covetrus announced the expansion of its' site in Arizona, increasing the company’s pharmacy capabilities for producing compounded products for use in veterinary clinics and pet owners' homes throughout the US
Read More